An amendment to this paper has been published and can be accessed via a link at the top of the paper.,
Erasmus MC: University Medical Center Rotterdam

Ossenkoppele, G.J. (G. J.), Breems, D.A. (D. A.), Stuessi, G. (G.), van Norden, Y, Bargetzi, M, Biemond, B.J, … Kuball, J. (2020). Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS (Leukemia, (2020), 34, 7, (1751-1759), 10.1038/s41375-020-0725-0). Leukemia. doi:10.1038/s41375-020-0994-7